Compare Dollar General Corp. (DG) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dollar General Corp. vs Recursion Pharmaceuticals Inc — how do they compare? Dollar General Corp. trades at $120.1 (market cap $26.49B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Dollar General Corp. is far larger — about 14.6× Recursion Pharmaceuticals Inc's market cap, and Dollar General Corp. pays a 1.97% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| DG | RXRX | |
|---|---|---|
Market Cap | $26.49B | $1.81B |
Sector | Consumer Staples | Health |
52-Week High | $156.26 | $6.79 |
52-Week Low | $95.94 | $2.84 |
Enterprise Value | $40.93B | $1.33B |
Dividend Yield | 1.97% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dollar General Corp.
A leading American discount retailer, Dollar General operates over 18,000 stores in 47 states, selling branded and private-label products across a wide variety of categories. In fiscal 2021, 77% of net sales came from consumables (including paper and cleaning products, packaged and perishable food, tobacco, and health and beauty items), 12% from seasonal merchandise (such as toys, greeting cards, decorations, and gardening supplies), 7% from home products (for example, kitchen supplies, small appliances, and cookware), and 4% from basic apparel. Stores average roughly 7,400 square feet, and about 75% of Dollar General locations are in towns of 20,000 or fewer people. The firm emphasizes value, with most of its items sold at everyday low prices of $5 or less.
Read more on DG →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
